Erik Folch MD, MSc was born and raised in Mexico City. He received his medical degree from Universidad Nacional Autónoma de Mexico, and Masters of Science in Clinical Research from Emory University. He trained in Internal Medicine at Emory University and Pulmonary Critical Care and Interventional Pulmonary at Cleveland Clinic. He is currently the Chief of the Complex Chest Diseases Center and Co-Director of Interventional Pulmonary at Massachusetts General Hospital, Harvard Medical School. He has authored over 120 peer-reviewed articles. He has mentored 40 dedicated Interventional Pulmonary fellows in the last 11 years. He has experience in designing clinical trials and has led multi-center clinical trials in navigation and robotic bronchoscopy.

ResearcherID L-4429-2016
ORCID 0000-0002-8074-0900

Dr Ng is Professor in Thoracic Surgery at Prince of Wales Hospital, The Chinese University of Hong Kong, and Honorary Consultant Surgeon at New Territory East Cluster (NTEC) hospitals in Hong Kong. He graduated from Imperial College, London in 1999, and received his FRCS in 2007.

Dr Ng is a pioneer in Single Port (Uniportal) VATS in the Asia-Pacific region, performing the first single port VATS lobectomy in Hong Kong in 2012. His interest in hybrid operating room (HOR) image-guided surgery led to world's first publications of HOR use in single port VATS major lung resection (iVATS) 2015, and image-guided electromagnetic navigation bronchoscopy (iENB) 2016. His team has since developed SuperD transbronchial microwave ablation in 2019, mobile-CT Cios Spin utilization 2020, Auris Monarch procedures in 2021, RAB microwave ablations in 2022, and Galaxy RAB procedures in 2023. He is Co-PI/PI of NAVABLATE, TARGET, INCITE-ES, PSR-EMPRINT, POWER, TiLT studies investigating utilization of navigation & robotic assisted bronchoscopy in diagnosis and different therapies.

His academic contributions include over 280 publications in indexed international journals, 24 book chapters (including in Pearson's Thoracic & Esophageal Surgery 3rd & 4th Eds, Shield's Thoracic Surgery 8th Eds). Dr Ng is the corresponding Editor of the book Atlas of Uniportal Video Assisted Thoracic Surgery (Springer Science), the standard text for uniportal VATS surgeons, and Associate Editor of the book Lung Cancer (1st & 2nd Editions).

ACADEMIC QUALIFICATIONS & AWARDS
M.B., Ch.B. 2017 The Chinese University of Hong Kong
M.B., Ch.B. Dean’s list 2014-2015 The Chinese University of Hong Kong
Dr. Tong Tai-ping Memorial Scholarship in Medicine 2015-2016 The Chinese University of Hong Kong
MCSHK The College of Surgeons of Hong Kong
Furuse Award 2023 Awardee ASCVTS 2023 Busan

TRAINING
09/2018 Basic surgical skills course
11/2018 Core clinical competency course
11/2018 NTEC basic surgical training programme
11/2018 Respiratory failure management course
03/2019 Basic point-of-care ultrasound course for surgeons
02/2023 Southeast Asia VATS lobectomy & chest wall reconstruction workup

Employment Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine
Chief Physician, Doctoral advisor
Director, Department of Respiratory Endoscopy and Interventional Pulmonology
Executive Deputy Director, Department of Respiratory and Critical Care Medicine

Memberships/Committee Assignments

• Head – Shanghai Engineering Research Center of Respiratory Endoscopy
• Head – Interventional Pulmonology Special Committee of China Association for Promotion of Health Science and Technology
• Deputy Head – Youth Committee of the Chinese Thoracic Society
• Deputy Head – Interventional Pulmonology Group of Chinese Thoracic Society
• Designate Head – Minimally Invasive Interventional Respiratory Branch of the China Medicine Education Association
• Secretary – Respiratory Medicine Committee of Shanghai Medical Association
• Head – Intervention Pulmonology Group of Respiratory Medicine Committee of Shanghai Medical Association
• Member – International Association for the Study of Lung Cancer
• Member – American Thoracic Society
• Editorial Board – Respiration
• Editorial Board – Endoscopic Ultrasound
• Visiting Professor – Chest Hospital Affiliated to University of Heidelberg, Germany

Education
1999-2002
Kaohsiung senior high school, Kaohsiung, Taiwan
2003-2010
National Taiwan University, School of medicine
2016-present
Institute of Biomedical Engineering, National Taiwan University

Experience
2011-2013
Residency, Department of Surgery, National Taiwan University Hospital
2013-2015
Residency, Department of Thoracic Surgery, National Taiwan University Hospital
2015-2016
Chief resident, Department of Thoracic Surgery, National Taiwan University Hospital
2016-present
Attending physician Department of Thoracic Surgery, National Taiwan University Hospital, Hsin-Chu Branch
2018-2020
Clinical lecturer, National Taiwan University Hospital, Department of Surgery
2019-2020
Visiting scholar, Department of Thoracic Surgery, University of Tokyo Hospital, Japan
2020-present
Attending physician Department of Thoracic Surgery, National Taiwan University Hospital, Hsin-Chu Biomedical Park Branch
2021-present
Assistant professor, National Taiwan University Hospital, Department of Surgery

Biography Shun-Mao Yang, MD, was appointed as a clinical instructor in Thoracic Surgery in 2017, having completed Thoracic Surgery Fellowship at National Taiwan University Hospital. Dr. Yang received his Medical Degree (2010) from the National Taiwan University, school of medicine, and completed his General Surgery residency (2013) and Thoracic Surgery residency (2016) at National Taiwan University Hospital.

Clinical Specialization
Dr. Yang specializes in all areas of general thoracic surgery, minimally invasive thoracic surgery, image-guided thoracic surgery, lung transplantation.

Research Interest
Dr. Yang research efforts include quantitative analysis of thoracic image and image-guided thoracic surgical procedures.

Director of Department of Respiratory Medicine
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou
China

• Deputy Director of GIRH
• Deputy Director, National Center for Respiratory Medicine
• Vice President of China Thoracic Society
• President, Group of Interventional Respiratory Diseases of CTS
• President, Respiratory Committee of China Association of Medical Equipment
• Member of Standing Committee, Digestive Endoscopy of Chinese Medical Doctor Association
• President, Respiratory Committee of Guangdong Medical Association
• Member of WABIP
• PI of specific national key projects
• Core member of the "National Innovation Competition Award"

Dr. Joyce Chan is a resident specialist in Cardiothoracic Surgery at Prince of Wales Hospital Hong Kong, and has been working with Professor Calvin Ng in electromagnetic navigation bronchoscopy (ENB)-related procedures. Since April 2019 she has been part of the first team in Asia to pioneer ENB microwave ablation of lung cancers in hybrid operating rooms.

Qualifications and Appointments
MBBS(Hons), the University of Hong Kong
MRCS(HK), MRCS (Edinburgh)
FRCS(HK), FRCS (Edinburgh)
Resident specialist, Division of Cardiothoracic Surgery, Prince of Wales Hospital
Honorary Clinical Tutor, the Chinese University of Hong Kong

Professional Experience
2016-2018 Resident (Basic Training), General Surgery
2018-2023 Resident (Higher Training), Cardiothoracic Surgery, Prince of Wales Hospital; Queen Mary Hospital, Queen Elizabeth Hospital

Key Publications
Chan JWY, Lau RWH, Ngai JCL, Tsoi C, Chu CM, Mok TSK, Ng CSH. Transbronchial microwave ablation of lung nodules with electromagnetic navigation bronchoscopy guidance-a novel technique and initial experience with 30 cases. Transl Lung Cancer Res. 2021 Apr;10(4):1608-1622.
Chan JWY, Lau RWH, Chu CM, Ng CSH. Expanding the scope of electromagnetic navigation bronchoscopy-guided transbronchial biopsy and ablation with mobile 3D C-arm Machine Cios Spin®-feasibility and challenges. Transl Lung Cancer Res. 2021 Oct;10(10):4043-4046.
Chan JWY, Siu ICH, Chang ATC, Li MSC, Lau RWH, Mok TSK, Ng CSH. Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now? Cancers (Basel). 2023 Feb 8;15(4):1068.
Chan JWY, Lau RWH, Chang ATC, Siu ICH, Chu CM, Mok TSK, Ng CSH. Concomitant Electromagnetic Navigation Transbronchial Microwave Ablation of Multiple Lung Nodules is Safe, Time-saving and Cost-effective. J Thorac Cardiovasc Surgery, in press, available online Aug 2023

Dr. CM Chu is a Consultant Radiologist with subspecialty training in Interventional Radiology. Dr. Chu completed his basic and higher radiology training in Prince of Wales Hospital in Hong Kong. He also completed his overseas Interventional Radiology observership programs in Memorial Sloan-Kettering Cancer Center and Johns Hopkins Hospital in the United States. He is currently the Interventional Radiology service coordinator, Vascular & Interventional Radiology subspecialty trainer and Gastrointestinal & Hepatobiliary Radiology subspecialty co-trainer in Prince of Wales Hospital. He is also Honorary Associate Professor of the Chinese University of Hong Kong.

Professional Memberships / Fellowships
European Congress of Radiology (ECR)
Cardiovascular and Interventional Radiological Society of Europe (CIRSE)
Royal College of Radiologists (RCR)
Hong Kong Academy of Medicine (HKAM) Hong Kong College of Radiologists (HKCR)
Hong Kong Society of Interventional Radiology (HKSIR)
Hong Kong Society of Diagnostic Radiologists (HKSDR)
Japan Radiological Society (JRS)
Korean Society of Radiology (KSR)

Research Summary / Clinical Interests
HCC endovascular and ablative treatment
Endovascular treatment of TAA
Imaging guided thoracic and body procedures
Endovascular dialysis treatment
Imaging guided procedures for SBRT Ablative treatment of adrenal, renal, lung and thyroid lesions
Mechanical Thrombectomy in Acute Ischemic Stroke

Teaching
Chinese University of Hong Kong
- Department of Imaging and Interventional Radiology

Hospital
Prince of Wales Hospital
- Department of Imaging and Interventional Radiology

Dr Lau Wing Hung graduated from the Chinese University of Hong Kong and obtained Fellowships of the College of Surgeons of Hong Kong and the Royal College of Surgeons of Edinburgh. She is currently working as Consultant in Cardiothoracic Surgery in Prince of Wales Hospital in Hong Kong.

Dr Lau has special interests in minimally invasive thoracic surgery (including Single Port VATS), interventional bronchoscopy and endobronchial ablation of pulmonary neoplasm, chest wall resection, thoracic trauma and innovation in thoracic surgery. She is experienced in Image-guided Electromagnetic Navigation Bronchoscopy (iENB) and minimally invasive lung resection in the hybrid operating room setting (iVATS).

She has co-authored over 50 indexed articles in international journals (including JCO, EJCTS, JTCVS, ATS, JTO). She is involved in multiple clinical trials related to navigational bronchoscopy and endobronchial ablation. She is also the winner of the APSR 2016 Annual Meeting Travel Scholarship Prize. Dr Lau is frequently invited to contribute as faculty in international conferences and workshops on thoracic surgery.

Dr. Michael Pritchett is an advanced bronchoscopist who is board certified in pulmonary disease and critical care medicine. He received his undergraduate degree from the University of Florida. He then attended medical school at Nova Southeastern University where he simultaneously received his medical degree and a master’s degree in public health. He completed his residency in Internal Medicine at Mt. Sinai Medical Center in Miami Beach, FL and then his fellowship in Pulmonary & Critical Care Medicine at St. Elizabeth's Medical Center, Tufts University School of Medicine in Boston, MA.

Since completing fellowship, he has been in private practice with the Pinehurst Medical Clinic in Pinehurst, NC for 15 years. He holds privileges at FirstHealth of the Carolinas, a 4-hospital system in central North Carolina. He serves as the Director of Thoracic Oncology and also the Director of the Chest Center of the Carolinas, a multidisciplinary thoracic oncology clinic. He has previously served as the Medical Director of Critical Care at FirstHealth Moore Regional Hospital (40-ICU beds). He is active in multiple clinical trials as principle investigator in areas of advanced bronchoscopy, thoracic oncology, molecular pathology, COPD, asthma and pulmonary arterial hypertension. He has been an author/co-author on multiple studies in these areas.

Dr. Pritchett is most well-known for his pioneering work on the use of intraoperative cone-beam CT (CBCT) to assist with biopsy of peripheral nodules. This technique has been shown to significantly increase the diagnostic yield of guided bronchoscopy for small peripheral nodules. This innovative work with CBCT has led directly to being able to perform first-in-human trials with an FDA-approved device for bronchoscopic microwave ablation of peripheral lung tumors. Dr. Pritchett has also been the first in the U.S. to perform robotic-assisted navigation bronchoscopy with the Intuitive Ion endoluminal robotic platform.

Agathe SEGUIN-GIVELET was qualified from the French University of Paris and was awarded a DPhil for her research into tracheal replacement thanks to a fellowship at center for cardiovascular repair, Minneapolis, Minnesota.

Dr A Seguin-Givelet worked for over 10 years as thoracic and vascular surgeon at Avicenne Hospital, Public Health institution near Paris. Then she decided to focus on thoracic surgery and mainly lung tumors. She moved to Institute Mutualist Montsouris surgical unit in 2015 in Paris and was chosen as the Head of department since 2020.

Deeply involved in MIS with VATS and RATS programs, she has a major experience in segmentectomies thanks to the department which has the largest European experience in this field. She leads the IMM thoracic team to organize successful international sublobar conferences (2018, 2019, 2021, 2023, next 2025). Her interest includes the relationship of service development to outcomes, image-guidance for thoracic surgery and guided bronchoscopy for therapy. She went on to do the first in the Europe (except UK) endobronchial microwave ablation of lung tumor in December 2022.

Professor Tony S.K. Mok was trained at the University of Alberta, Canada and he subsequently completed a fellowship in medical oncology at the Princess Margaret Hospital in Toronto. After working as a community oncologist in Toronto, Canada for seven years, he returned to Hong Kong in 1996 to pursue an academic career.

Professor Mok is the Li Shu Fan Medical Foundation endowed Professor and Chairman of Department of Clinical Oncology at The Chinese University of Hong Kong. His main research interest focuses on biomarker and molecular targeted therapy in lung cancer. He was the Principal Investigator and first author on the landmark IRESSA® Pan-Asia Study (IPASS), which was the first study that confirmed the application of precision medicine for advanced lung cancer. He has also led and co-led multiple international phase III studies including the FASTACT 2, PROFILE 1014, IMPRESS, ARCHER 1050, ALEX, AURA 3 and KEYNOTE 042. These projects address various aspects on management of advanced lung cancer, and basically have defined the current practice. He dedicates his work on precision medicine for lung cancer by also engaging in clinical research on oncogene driven lung cancer and immunotherapy. His work has been adopted by multiple international guidelines including NCCN, AMP/IASLC/CAP, ASCO and ESMO. He also contributes to the development of clinical research infra-structure in China and Asia. He cofounded the Lung Cancer Research Group, Chinese Thoracic Oncology Research Group and Asia Thoracic Oncology Research Group.

Professor Mok has contributed to over 308 articles in international peer-reviewed journals, including the New England Journal of Medicine, Science, Lancet, Nature Medicine and Journal of Clinical Oncology, and published multiple editorials and textbooks. He served as an Associate Editor for thoracic oncology for the Journal of Clinical Oncology and other international journals. He is the Past President, Past Treasurer of the International Association for the Study of Lung Cancer (IASLC) and Past Board of Director for ASCO. He is a member of the Board of Directors for ACTG-Sanomics Group, AstraZeneca, Aurora Tele-Oncology, HutchMed (China) and St. Stephen’s College & Preparatory School. He is active in international education activity and has made significant contributions to AACR, ASCO, CSCO and ESMO. His work was recognized by numerous awards including Bonnie Addario Award in 2015, Fellowship of the American Society of Clinical Oncology (FASCO) in 2017, Paul 2020, Jr Scientific Award in 2017, National Science and Technology Progress Award in 2017, CSCO Annual Achievement Award in 2017, ESMO Lifetime Achievement Award in 2018, The 6th Kobayashi Foundation Award, Giant of Cancer Care 2020 and SingTao Hong Kong Leader of the Year 2020 Award. His recent article in the New England Journal of Medicine has been selected as one of the most “Notable Articles in 2017”. He is one of the “Highly Cited Researchers” by Clarivate Analytics for four consecutive years from 2018 to 2022. He was awarded with the Bronze Bauhinia Star (BBS) by the Government of Hong Kong Special Administrative Region in 2022 to recognize his dedicated service in public affairs.

Dr. Michael J. Simoff, M.D., FACP, FCCP, is an accomplished medical professional whose career spans exceptional clinical practice, groundbreaking research, and influential scholarly contributions.

Dr. Simoff completed his M.D. from Wayne State University School of Medicine in 1990, following a distinguished undergraduate journey. He has since gained extensive postgraduate training, including a Pulmonary and Critical Care Medicine fellowship at Henry Ford Hospital, where he has been a Senior Staff Physician for several years.

He holds various faculty positions, notably as a Professor of Medicine and a Clinical Professor of Medicine at different universities. Dr. Simoff's extensive clinical appointments include roles like Director of Bronchoscopy and Interventional Pulmonology Services, Director of Lung Cancer Screening Program, and Co-Director of the Thoracic Oncology Program at Henry Ford Hospital.

His commitment extends to his engagement in numerous professional societies and associations, such as the American College of Physicians, American College of Chest Physicians, and the International Association for the Study of Lung Cancer.

As a renowned figure in Pulmonary and Critical Care Medicine, Dr. Simoff leads a robust clinical practice that centers on interventional pulmonology, complex airways disease, critical care medicine, and lung cancer. His expertise encompasses consultations for complex pulmonary conditions, while also serving as an inpatient consultant for critical care, lung cancer, pleural disease, and complex airways issues. His pioneering spirit extends to the forefront of medical technology, where he explores innovations like robotics, gene therapy, stem cell therapy, advanced optics, and nanotechnology.

Dr. Simoff's leadership shines in his role as overseer of the Henry Ford Health System Lung Cancer Screening Program, a pivotal initiative managing lung cancer screening across the entire system. Beyond patient care, his dedication to public health is evident in his engagement with population-based sciences research teams focused on lung cancer screening and smoking cessation. His global impact extends to international medical programs, where he contributes his expertise to China, Macedonia, and Saudi Arabia.

In the realm of scholarship, Dr. Simoff's influence is profound. His involvement in grant and review committees for organizations like the British Lung Foundation and the CHEST Foundation/LUNGevity Foundation underscores his commitment to advancing medical knowledge. He has served as an Associate Editor for the Journal of Bronchology and contributed to the editorial boards of respected journals, including Pleura and Annals of Occupational & Pulmonary Medicine. His meticulous manuscript reviews for esteemed publications such as Lung Cancer and Chest showcase his dedication to quality research.

Dr. Simoff's dedication to shaping the future of medicine is further demonstrated by his involvement in international clinics, promotion committees, and academic advancement assessments. His holistic approach to healthcare, combining clinical practice, research, and scholarly contributions, places him at the forefront of medical excellence, leaving an indelible mark on patient care and medical advancement.

Dr. Otis B. Rickman is a Board Certified, Interventional Pulmonologist at Vanderbilt University Medical Center. He earned his Bachelor of Science in Biology ('94) and Doctor of Osteopathic Medicine ('98) from Oklahoma State University. Internal medicine residency and pulmonary and critical care medicine fellowship at Mayo Clinic in Rochester, MN. Immediately after fellowship training in 2004, he joined the faculty at Mayo Clinic as a member of the advanced bronchoscopy and interventional pulmonology group. Dr. Rickman moved to Vanderbilt University Medical Center in Nashville, TN, in the late summer of 2009, where he founded the Interventional Pulmonology section. He currently serves as the Founding Director of Interventional Pulmonology, Bronchoscopy and Lung Nodule Clinic. He is the Co-Director of the Lung Screening Program and Associate Professor of Medicine and Thoracic Surgery at Vanderbilt University School of Medicine. He has been recognized by the American College of Chest Physicians as a Distinguished CHEST Educator and is actively involved in procedural education at the local, national, and international levels. His clinical and translational research interests focus on medical devices, early diagnosis, and prevention of lung cancer. His clinical work is on lung nodules, lung cancer, pleural diseases and interventional pulmonology.

Kelvin Lau qualified from the University of Oxford and was awarded a DPhil for his research into tumour targeting. His surgical fellowship took him to the Chinese University of Hong Kong where he was reaquainted with his primary school classmate Calvin Ng.

He was appointed as the first consultant thoracic surgeon at Barts to set up the thoracic surgery service. Together with his visionary pulmonology and oncology colleagues, they led the Barts Thorax Centre to becoming the leading thoracic surgery unit with the highest resection rate in the UK whilst also having the best clinical outcomes with the lowest mortality, and built the largest robotic surgery, segmentectomy, navigation bronchoscopy, mesothelioma surgery and lung volume reduction programmes in the UK.

In November 2015 he led the first team in Europe to successfully use the latest version of navigation bronchoscopy, and went on to do the first in the world endobronchial microwave ablation of lung tumour in February 2018.

His interests include the relationship of service development to outcomes, image-guidance for thoracic surgery and guided bronchoscopy for therapy. He is principal investigator for the NAVIGATE, NAVABLATE, MARS2, RAMON and Ion trials.

Higher Education
1984 – 1988 Technion – Israel Institute of Technology – Faculty of Medicine, Bachelor of science in Medical Sciences (B.Sc.)
1988 – 1991 Technion- Israel Institute of Technology – Faculty of Medicine, M.D

Professional Experience
1990 – 1991 Intern, Beney Zion Medical Center
1995 – 1997 Diving and Hyperbaric Physician, Israel Naval Medical Institute
1997 – 2000 Resident , Department of Internal Medicine A, Carmel Medical Center
2000 - 2003 Assistant Director , The Israel Naval Medical Institute
2003 - 2005 - Resident , Department of Pulmonology , Rambam Medical center
2005 - 10/2010 - Director , The Israeli Naval Medical Institute
10/2010 – Senior Respiratory physician - Caramel medical center
1/2013 – Director of interventional pulmonology unit – Carmel Medical Center

Special interest in early lung cancer diagnosis and treatment. using slim /ultra slim scopes and Advanced intraprocedural imaging

Dr. Amit "Bobby" Mahajan is the medical director of interventional pulmonology for the Inova Health System and the Complex Airways and Pleural Disease program at the Inova Fairfax Medical Center. He is board certified in internal medicine, pulmonary medicine, critical care medicine, and interventional pulmonology. Dr. Mahajan serves on the board of directors for the American Association of Bronchoscopy and Interventional Pulmonology (AABIP) and the American Association of Respiratory Care (AARC). He is also a national volunteer spokesman for the American Lung Association (ALA). Dr. Mahajan completed his undergraduate degree in English at Williams College in Williamstown, Massachusetts, medical school at the University of Toledo School of Medicine, and his internal medicine residency, chief residency, and pulmonary and critical care fellowship at the University of Chicago. Dr. Mahajan completed his interventional pulmonology fellowship at the Harvard University Hospital System in The Massachusetts General Hospital and The Beth Israel Deaconess Medical Center. He has received multiple awards including induction to the Alpha Omega Alpha Society and the Gold Humanism Honor Society. In 2022, he was awarded the White House Lifetime Achievement Award for his work in interventional pulmonology and his contributions to the COVID-19 pandemic response.

Dr. Mahajan performs both diagnostic and therapeutic procedures for malignant and benign diseases of the chest. He has a focus on rigid bronchoscopy for endobronchial tumors, endobronchial ultrasound bronchoscopy (EBUS), electromagnetic navigation bronchoscopy (ENB), and bronchoscopic lung volume reduction (BLVR). He also performs various other procedures in the airway along with various pleural procedures. He has a significant interest in research and participates in both investigator and industry sponsored studies. He oversees the Inova Saville incidental lung nodule program and the Inova Saville lung cancer screening program. He is extensively published in the field of interventional pulmonology and sits on multiple advisory boards.

Dr. Mahajan is a native of Toledo, Ohio and currently resides in Vienna, VA with his wife and three children. He enjoys playing basketball and watching movies with his family.

Dr. TAM Chi Chun Terence is a specialist in respiratory medicine. He received his MBBS degree from HKU in 2001 and pursued his post-fellowship training in interventional pulmonology at the University of Heidelberg in Germany, and the St. Mariana University School of Medicine in Japan.

Dr. Tam has extensive experience in advanced bronchoscopic and pleural procedures to manage lung nodules, lung cancer, hemoptysis, airway obstruction, asthma, chronic obstructive pulmonary disease (COPD), pneumothorax and pleural effusion. He is also well-versed in the treatment of lung cancer and non-cancerous lung conditions including pneumonia, interstitial lung diseases and obstructive sleep apnea.

Prior to joining private practice, Dr. Tam worked for over 20 years in Queen Mary Hospital, where he developed the interventional pulmonology service through the introduction and improvement of multiple technologies and techniques, such as navigational bronchoscopy, perioperative tumor localization, Dyna-CT-guided bronchoscopy, and ultrasound- guided pleural sampling. He serves as the secretary general to the Asia-Pacific Interventional Pulmonology Alliance (APIPA) and drafting the latest local guideline on Procedural Safety as the convenor of the Special Interest Group in Interventional Pulmonology under the Hong Kong Thoracic Society (HKTS).

Dr. Tam is currently an Honorary Clinical Assistant Professor in the Department of Medicine at the University of Hong Kong (HKU), where he has been actively involved in academic research and teaching. He has co-authored more than 40 publications in peer-reviewed journals on topics such as asthma, COPD, bronchiectasis and lung cancer. As a medical supervisor for HKU's Biomedical Engineering Program, he has overseen projects related to artificial intelligence (AI)- based pleural ultrasound image analysis, electrical impedance tomography applications in pulmonology, and AI-driven airway segmentation to support navigational bronchoscopy.

Dr. Tam is a sought-after speaker and has given talks on diverse topics, both locally and internationally, to the general public, medical professionals, and fellow respirologists.

Brian Shaller is an interventional pulmonologist and Assistant Professor of Medicine in the Division of Pulmonary, Allergy & Critical Care Medicine at Stanford University. He trained in Internal Medicine and Pulmonary and Critical Care Medicine at Stanford, after which he completed his fellowship in Interventional Pulmonary Medicine at the Cleveland Clinic.

Dr. Shaller’s clinical and research interests include the early diagnosis of lung cancer using intraprocedural cone beam computed tomography and robotic-assisted bronchoscopy, the management of lung transplant airway complications, and the treatment of benign central airway obstruction. He is a co-investigator at Stanford for Ethicon’s POWER study – an international, multicenter prospective trial of transbronchial microwave ablation for oligometastatic tumors in the lung.

Dr. Shaller is also passionate about procedural education and training. He helped establish Stanford University’s Interventional Pulmonology Fellowship Program, for which he currently serves as Associate Program Director. He is a member of the American Association for Bronchology and Interventional Pulmonology/Association of Interventional Pulmonology Program Directors IP Fellowship Accreditation Committee. He is also a co-director of Stanford’s "Cone Beam CT in Advanced Bronchoscopy" course, which aims to disseminate knowledge and provide hands-on experience in the use of advanced intraprocedural imaging in peripheral bronchoscopy.